KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Exchange Rate Effect (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 17 years of Exchange Rate Effect data on record, last reported at $7.3 million in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 115.43% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $90.9 million, up 313.38%, while the annual FY2025 figure was $90.9 million, 313.38% up from the prior year.
  • Exchange Rate Effect reached $7.3 million in Q4 2025 per VRTX's latest filing, up from -$4.1 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $57.2 million in Q2 2025 and bottomed at -$47.3 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $1.6 million, with a median of -$3.2 million recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: crashed 747.5% in 2022, then skyrocketed 2388.0% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$4.9 million in 2021, then skyrocketed by 932.65% to $40.8 million in 2022, then crashed by 32.84% to $27.4 million in 2023, then crashed by 272.63% to -$47.3 million in 2024, then skyrocketed by 115.43% to $7.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $7.3 million in Q4 2025, -$4.1 million in Q3 2025, and $57.2 million in Q2 2025.